Mutational analysis of TP53 and p21 in familial and sporadic ovarian cancer in Japan
- 28 February 2006
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 100 (2) , 365-371
- https://doi.org/10.1016/j.ygyno.2005.09.010
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Inactivation of BRCA1 and BRCA2 in Ovarian CancerJNCI Journal of the National Cancer Institute, 2002
- Cell Proliferation and Apoptosis in BRCA-Associated Hereditary Ovarian CancerGynecologic Oncology, 2002
- DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesisMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2002
- Expression of Cell-Cycle Mediators in Ovarian Cancer Cells after Transfection with p16INK4a, p21WAF1/Cip-1, and p53Gynecologic Oncology, 2001
- Increased frequency ofTP53 mutations inBRCA1 andBRCA2 ovarian tumoursGenes, Chromosomes and Cancer, 1999
- Frequency of p53 Mutations in Breast Carcinomas From Ashkenazi Jewish Carriers of BRCA1 MutationsJNCI Journal of the National Cancer Institute, 1999
- Incidence of loss of heterozygosity at p53 and BRCA1 loci in serous surface carcinomaHuman Pathology, 1999
- p53 mutation with frequent novel codons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumoursOncogene, 1998
- Functions of the BRCA1 and BRCA2 genesCurrent Opinion in Genetics & Development, 1998
- The p53 NetworkJournal of Biological Chemistry, 1998